RxDoctor Payments Data

Uchenna Nwoko

Physician Assistant · Greensboro, NCNPI 1811662281

Payments from drug & device makers

$7,391in general payments, 2019–2025

Across 327 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$982
  • Neurocrine Biosciences, Inc.$890
  • Johnson & Johnson$802
  • Teva Pharmaceuticals USA, Inc.$621
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$7,14097%
  • Education$2513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,391 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$6,218
Medicare patients
19
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine15$76,488
Aripiprazole45$5,420
Quetiapine Fumarate54$935
Trazodone Hcl83$812
Ramelteon11$747
Doxepin Hcl19$610
Hydroxyzine Hcl26$517
Buspirone Hcl31$358
Fluoxetine Hcl40$330
Gabapentin25$278
Prazosin Hcl11$237
Hydroxyzine Pamoate13$232
Bupropion XlBupropion Hcl19$210
Mirtazapine23$174
Lamotrigine23$153

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$621$76,48815 claims
Almatica Pharma LLCSertraline Hcl$31$13017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →